Marshall University in Huntington, W.Va., recently received a $5 million endowment for its sports medicine translational research center from the Cline Family Foundation and another $5 million from the Virginia Research Trust Fund's Bucks for Brains program, according to a…
The Latest
Columbus, Ohio-based OrthoNeuro opened the state's first Orthopedic Urgent Care Center in New Albany (Ohio) Orthopaedic Institute, according to a company news release.
A team physician for the Arizona Cardinals and Phoenix Coyotes and consultant with the Oakland Athletics, Douglas Freedberg, MD, discusses the finer points of being a sports medicine and team physician today. Dr. Freedberg is a sports medicine orthopedic surgeon…
Philadelphia Phillies pitcher Jose Contreras recently received a platelet-rich plasma injection to relieve pain in his right forearm, according to an MLB report.
Franklin, Tenn.-based medical management services company MedSolutions recently released its Lumbar Spine Surgery Management Program to provide guidance for clinical appropriateness of spine surgery for patients suffering from back pain, trauma and degeneration, according to a company news release.
MiMedx Group, a Marietta, Ga.-based manufacturer of biomaterials and bioimplants, reported $1.9 million in revenue for the second quarter of 2011, which is a six-fold increase over the second quarter of 2010, according to a company news release.
Nearly 80 percent of respondents have concerns about the safety of their electronic medical records, according to a recent Xerox survey. Respondents also said computer hackers, damaged EMRs and misuse of medical information are three of their biggest worries with…
When an orthopedic practice includes physical therapy, there is a benchmark of 4.6 weighted procedures per provider work hour, according to an AAOS Now report.
Workers who sustain work-related back injuries, especially younger adults and African Americans, have longer financial and domestic duress that escalates with each year after a claim settlement, according to a study published in Spine.
According to a Cephalon news release, the FDA has approved a risk evaluation and mitigation strategy for Cephalon's Fentora and Actiq drugs to manage breakthrough pain in opioid-tolerant patients with cancer.